ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Reynolds Unveils New Cigarette ; Cullen, Others Skeptical

September 18, 1987

The NLST at a Glance

August 2, 2013

Senate Outlines Budget Priorities In Bill Report

July 19, 1991

ACR Presses Effort to Demonstrate Radiotherapy Is As Good As Or Better Than Surgery

October 2, 1981

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

June 18, 1993

NCI To Fund Partnerships Between Cancer Centers and Minority Institutions

November 12, 1999